Yu, H.-H.; Yonemura, Y.; Ng, H.-J.; Lee, M.-C.; Su, B.-C.; Hsieh, M.-C.
Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery. Cancers 2023, 15, 3401.
https://doi.org/10.3390/cancers15133401
AMA Style
Yu H-H, Yonemura Y, Ng H-J, Lee M-C, Su B-C, Hsieh M-C.
Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery. Cancers. 2023; 15(13):3401.
https://doi.org/10.3390/cancers15133401
Chicago/Turabian Style
Yu, Hsin-Hsien, Yutaka Yonemura, Hui-Ji Ng, Ming-Che Lee, Bor-Chyuan Su, and Mao-Chih Hsieh.
2023. "Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery" Cancers 15, no. 13: 3401.
https://doi.org/10.3390/cancers15133401
APA Style
Yu, H.-H., Yonemura, Y., Ng, H.-J., Lee, M.-C., Su, B.-C., & Hsieh, M.-C.
(2023). Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery. Cancers, 15(13), 3401.
https://doi.org/10.3390/cancers15133401
